Naamidine a intensifies the phosphotransferase activity of extracellular signal-regulated kinases causing a-431 cells to arrest in G1

Molecular Cancer Therapeutics

Volumn 2, Issue 8, 2003, Pages 747-751

  James, Robyn D ^a   Jones, David A ^b   Aalbersberg, William ^c   Ireland, Chris M ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF THE SOUTH PACIFIC   (Fiji)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; NAAMIDINE A;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; DOSE RESPONSE; DRUG EFFECT; HUMAN; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; G1 PHASE; HUMANS; IMIDAZOLES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 2942631728     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Aaronson, S. A. Growth factors and cancer. Science (Wash. DC), 254:1146-1153, 1991. (Pubitemid 21917439)
2. Jones, J. T., Akita, R. W., and Sliwkowski, M. X. Binding specificities and affinities of EGF domains for ErbB receptors. FEBS Lett., 447: 227-231, 1999. (Pubitemid 29146091)
3. Sebolt-Leopold, J. S. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene, 19: 6594-6599, 2000. (Pubitemid 32197697)
4. Freeman, M. Complexity of EGF-receptor signalling revealed in Drosophila.Curr. Opin. Genet. Dev, 8: 407-411, 1998. (Pubitemid 28412456)
5. Hai, T., and Hartman, M. G. The molecular biology and nomenclature of the activating transcription factor/camp responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene, 273: 1-11, 2001. (Pubitemid 32718721)
6. Yarden, Y., and Sliwkowski, M. X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol., 2: 127-137, 2001. (Pubitemid 33674041)
7. Masui, H., Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., and Mendelsohn, J. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor antibodies. Cancer Res., 44: 1002-1007, 1984. (Pubitemid 14152782)
8. Lyall, R. M., Zilberstein, A., Gazit, A., Gilon, C., Levitzki, A., and Schlessinger, J. Tyrphostins inhibit epidermal growth factor (EGF)-receptor kinase activity in living cells and EGF-stimulated cell proliferation. J. Biol. Chem., 264: 14503-9, 1989. (Pubitemid 19214287)
9. Carmely, S., and Kashman, Y. Naamines and Naamidines, novel imidazole alkaloids from the calcareous sponge Leucetta chagosensis. Tetrahedron Lett., 28: 3003-3006, 1987.
10. Copp, B. R., Fairchild, C. R., Cornell, L., Casazza, A., Robinson, S., and Ireland, C. M. Naamidine A is an antagonist of the epidermal growth factor receptor and an in vivo active antitumor agent. J. Med. Chem., 41:3909-3911, 1998. (Pubitemid 28447318)
11. Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., and McMahon, M. Raf induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21cip1. Mol. Cell. Biol., 17: 5598-5611, 1997. (Pubitemid 27357656)
12. Sewing, A., Wiseman, B., Lloyd, A. C., and Land, H. High-intensity Raf signal causes a cell cycle arrest mediated by p21cip1. Mol. Cell. Biol., 17:5588-5597, 1997. (Pubitemid 27357655)
13. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assesment of chemosensitivity testing. Cancer Res., 47:936-942, 1987. (Pubitemid 17027905)
14. Kameshita, I., and Fujisawa, H. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem., 183: 139-143, 1989. (Pubitemid 20009783)
15. Pumiglia, K. M., and Decker, S. J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA, 94: 448-452, 1997. (Pubitemid 27053653)
16. Patel, T., Gores, G. J., and Kaufmann, S. H. The role of proteases during apoptosis. FASEB J., 10: 587-597, 1996. (Pubitemid 26141170)
17. Karawya, E. M., and Wilson, S. H. Studies on catalytic subunits of mouse myeloma α-polymerase. J. Biol. Chem., 257: 13129-134, 1982.
18. Boulton, T. G., Nye, S., Robbins, D. J., Ip, N. Y., Radziejewska, E., Morgenbesser, S. D., DePhinho, R. A., Panayotatos, N., Cobb, M. H., and Yancopoulos, G. D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell, 65: 663-675, 1991.
19. Bottazzi, M. E., Zhu, X., Bohmer, R. M., and Assoian, R. K. Regulation of p21cip1 expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J. Cell Biol., 146:1255-1264, 1997. (Pubitemid 29477693)